Currently Speaking

In part two of this four-part series, Bill Current continues his conversation with Mike Jeffries of ClearStar to explore the history, evolution, and future of oral fluid drug testing.

Mike shares his firsthand experience helping introduce one of the first commercially available lab-based oral fluid testing options to the employment market and discusses the early adopters that helped demonstrate its value. Bill and Mike also examine ...

In the first episode of this four-part series, Bill Current speaks with Mike Jeffries of ClearStar about his decades-long career in the drug testing and employment screening industries. Mike shares how he entered the industry as workplace drug testing was beginning to take shape, reflects on the consolidation and technological changes he has witnessed, and explains how ClearStar supports consumer reporting agencies through drug tes...

Compliance is about more than following regulations. It is about building a culture of trust, education, and accountability.

In this episode of Currently Speaking, Bill Current is joined by Greg Henderson, founder of Federal Drug Testing Services and author of Trust But Verify: FAA Drug and Alcohol Compliance, What Every DER, Manager, and Executive Needs to Know. Greg shares the experiences that inspired his first industry book, dis...

In this episode, Bill Current examines the workplace safety implications of marijuana use, the misconceptions surrounding rescheduling, and why employers should remain focused on protecting employees, customers, and the public. He discusses what marijuana rescheduling does and does not mean, recent guidance from the U.S. Department of Transportation (DOT), and why employers continue to have the right and the responsibility to prohi...

In this episode of Currently Speaking, Bill Current sits down with Phil Dubois, Founder and CEO of Workplace Screening Intelligence, to discuss one of the most important issues facing employers today: marijuana rescheduling and its potential impact on workplace drug testing.As federal agencies move forward with efforts to reschedule marijuana, employers, drug testing providers, and safety professionals are asking critical questions...

As marijuana legalization continues to expand and the federal government moves forward with marijuana rescheduling, many employers and drug testing providers are asking an important question: What does the future hold for workplace drug testing?

In this episode of Currently Speaking, Bill Current reviews findings from Current Consulting Group’s 28th Annual Drug Testing Industry Survey and discusses what nearly 500 industry pro...

In this episode of Currently Speaking, Bill Current explains why regularly updating your drug testing policy is essential to maintaining a safe, compliant, and effective drug-free workplace program.

Drawing on findings from Current Consulting Group’s 2025 employer survey, Bill discusses how employers measure the return on investment of drug testing and why most organizations continue to view it as a highly effective tool for p...

In Part 1 of this episode of Currently Speaking, Bill Current sits down with Angela Moore, CEO of Cynergy Wellness, to discuss her remarkable career in the drug and alcohol testing industry. Angela shares how she got her start in the early days of federal drug testing regulations, her work with industry pioneer Dr. Murray Lappe, and the path that led her to helping build eScreen into one of the most influential brands in the indust...

In Part 2 of this episode of Currently Speaking, Bill Current continues his conversation with Angela Moore, CEO of Cynergy Wellness, focusing on the future of workplace screening and employee wellness. Angela discusses what has made the Synergy brand stand out, how the industry may evolve over the next decade, and why employers should think beyond drug-free policies toward broader drug-safe and wellness-focused strategies. The conv...

This episode of Currently Speaking dives into why rapid-result oral fluid testing is gaining traction, how solutions like OralTox® and OT-Scan® are improving efficiency and compliance, and what these advancements mean for employers navigating today’s hiring challenges.

The landscape of drug testing is rapidly evolving, and organizations must adapt to remain compliant and efficient. Rod Weis's insights provide a roadmap for lev...

In this episode of Currently Speaking, Bill Current follows up on his recent Current in 30 webinar, Addressing Marijuana in Your Drug Testing Policy: Complacency Is Not an Option, by answering several important questions that employers frequently ask about marijuana and workplace drug testing.

As marijuana legalization continues to expand across the United States, employers are facing new challenges when it comes to maintaining safe...

In this episode of Currently Speaking, Bill Current discusses the evolving conversation around marijuana legalization, particularly in light of a recent editorial from the New York Times that acknowledges the negative consequences of looser marijuana policies. The discussion covers the implications of marijuana reclassification, the rise in usage and addiction, and the impact on workplace safety. Current emphasizes the need for emp...

President Trump’s recent Executive Order to reclassify marijuana from a Schedule I to a Schedule III drug under the Drug Enforcement Administration has sparked debate about the future of workplace drug testing. Schedule I drugs are defined as having no accepted medical use and a high potential for abuse, while Schedule III drugs are considered to have a lower potential for dependence.Despite possible reclassification, most em...

The conversation around marijuana rescheduling is heating up! In this podcast episode, part 1 of a 2-part series, Bill Current, founder of Current Consulting Group, and Greg Henderson, founder of Federal Drug Testing Services, dive into marijuana rescheduling, common compliance misconceptions, and what employers need to know about workplace drug testing regulations. The discussion focuses on safety, federal oversight, and why curre...

As more employers remove marijuana from drug-testing panels, is it a costly mistake? According to Current Consulting Group’s 2025 Employer Drug Testing Survey, fewer companies are testing for cannabis—despite warnings from medical expert Dr. Marc Siegel, who calls marijuana “the most dangerous drug in America.”

In this episode of Currently Speaking, the podcast of the Current Consulting Group, we examine why ...

In this episode of Currently Speaking, we dive deep into the key findings of Current Consulting Group’s 2025 Employer Drug Testing Survey—one of the industry’s most trusted sources for workplace drug testing insights.

Join us as we break down what employers are learning about the effectiveness of drug testing, emerging workplace trends, and how evolving policies, substances, and testing technologies are shaping dr...

Illicit drug use in the workplace is more common than most employers realize — and it’s not just happening after hours. In this episode of Currently Speaking, Bill Current, Founder of the Current Consulting Group, dives into surprising new data revealing when, where, and with whom employees are using, buying, and even selling drugs at work.

From alarming survey results showing nearly 69% of illicit drug users admit using...